1. Home
  2. ARCT vs PMO Comparison

ARCT vs PMO Comparison

Compare ARCT & PMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • PMO
  • Stock Information
  • Founded
  • ARCT 2013
  • PMO 1993
  • Country
  • ARCT United States
  • PMO United States
  • Employees
  • ARCT N/A
  • PMO N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • PMO Finance Companies
  • Sector
  • ARCT Health Care
  • PMO Finance
  • Exchange
  • ARCT Nasdaq
  • PMO Nasdaq
  • Market Cap
  • ARCT 298.3M
  • PMO 287.4M
  • IPO Year
  • ARCT N/A
  • PMO N/A
  • Fundamental
  • Price
  • ARCT $11.86
  • PMO $10.00
  • Analyst Decision
  • ARCT Strong Buy
  • PMO
  • Analyst Count
  • ARCT 7
  • PMO 0
  • Target Price
  • ARCT $57.40
  • PMO N/A
  • AVG Volume (30 Days)
  • ARCT 410.5K
  • PMO 99.0K
  • Earning Date
  • ARCT 05-12-2025
  • PMO 01-01-0001
  • Dividend Yield
  • ARCT N/A
  • PMO 4.10%
  • EPS Growth
  • ARCT N/A
  • PMO N/A
  • EPS
  • ARCT N/A
  • PMO 0.42
  • Revenue
  • ARCT $143,680,000.00
  • PMO N/A
  • Revenue This Year
  • ARCT N/A
  • PMO N/A
  • Revenue Next Year
  • ARCT $44.93
  • PMO N/A
  • P/E Ratio
  • ARCT N/A
  • PMO $24.38
  • Revenue Growth
  • ARCT 15.38
  • PMO N/A
  • 52 Week Low
  • ARCT $8.04
  • PMO $8.57
  • 52 Week High
  • ARCT $45.00
  • PMO $10.68
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 50.74
  • PMO 54.64
  • Support Level
  • ARCT $10.70
  • PMO $9.84
  • Resistance Level
  • ARCT $13.10
  • PMO $10.07
  • Average True Range (ATR)
  • ARCT 0.89
  • PMO 0.09
  • MACD
  • ARCT -0.01
  • PMO 0.04
  • Stochastic Oscillator
  • ARCT 35.69
  • PMO 80.00

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About PMO Putnam Municipal Opportunities Trust

Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, tax bonds, local debt, state debt, and education.

Share on Social Networks: